UROY Uranium Royalty Corp.
Miscellaneous Metal Ores · Nasdaq · SEC CIK 2143673 · Fiscal year ends 04/30
Financial factors as of 2026-04-30 (FY2026), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY1,566.0%
TTM net income YoY992.6%
TTM EPS YoY825.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin30.6%
Operating margin25.9%
Net margin21.5%
FCF margin—
EBITDA margin25.9%
Returns
ROE15.2%
ROA13.7%
ROIC (approx.)30.1%
Asset turnover0.63x
Leverage & solvency
Liabilities / assets16.2%
Debt / equity0.00x
Current ratio5.94x
Interest coverage—
Cash quality & payout
Operating cash flow / net income4.43x
Accruals ratio-46.9%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-04-30 | FY20252025-04-30 | FY20242024-04-30 |
|---|---|---|---|
| Income statement | |||
| Revenue | $186.81M | $11.21M | $31.20M |
| Cost of revenue | $129.69M | $8.66M | $20.43M |
| Gross profit | $57.11M | $2.56M | $10.78M |
| SG&A expense | $5.29M | $4.80M | $4.97M |
| Operating income | $48.32M | -$3.44M | $5.09M |
| Interest expense | $0 | $303,000 | $0 |
| Pretax income | $54.64M | -$5.64M | $16.90M |
| Income tax | $14.39M | -$1.14M | $3.19M |
| Net income | $40.25M | -$4.51M | $13.71M |
| EBITDA | $48.43M | -$3.40M | $5.09M |
| EPS (basic) | 0.29 | -0.04 | 0.13 |
| EPS (diluted) | 0.29 | -0.04 | 0.12 |
| Weighted avg. shares (diluted) | 139.42M | 126.80M | 115.16M |
| Balance sheet | |||
| Cash & equivalents | $282.04M | $9.45M | $15.39M |
| Receivables | $59,000 | $31,000 | — |
| Inventory | $34.33M | $157.62M | $135.79M |
| Current assets | $329.30M | $172.59M | — |
| Total assets | $373.32M | $216.12M | — |
| Current liabilities | $55.48M | $739,000 | — |
| Short-term debt | $0 | — | — |
| Long-term debt | $0 | — | — |
| Total debt | $0 | — | — |
| Total liabilities | $60.55M | $1.02M | — |
| Shareholders' equity | $312.77M | $215.10M | $200.41M |
| Net debt | -$282.04M | — | — |
| Shares outstanding | 377.21M | 133.64M | — |
| Cash flow statement | |||
| Operating cash flow | $178.46M | -$15.06M | -$76.43M |
| Investing cash flow | $798,000 | -$8.59M | $32.49M |
| Financing cash flow | $93.70M | $18.45M | $49.24M |
| Depreciation & amortization | $111,000 | $47,000 | $0 |
| Stock-based compensation | $746,000 | $561,000 | $547,000 |
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.